SCHEMBL2725547

SCHEMBL2725547

Cc1csc([C@H]2CCCN2C(=O)c2cc(-c3nnc([C@@](C)(Cc4ccccc4)NC(=O)O)o3)cc(N(C)S(C)(=O)=O)n2)n1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 3/20 0.39
BACE2 Q9Y5Z0 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.34
USP30 Q70CQ3 1/20 0.34
TRPV1 Q8NER1 2/20 0.34
CPT2 P23786 1/20 0.32
CPT1A P50416 1/20 0.32
CPT1B Q92523 1/20 0.32
CPS1 P31327 1/20 0.32
POLB P06746 1/20 0.32
HCRTR1 O43613 2/20 0.32
HCRTR2 O43614 2/20 0.32
TRPC3 Q13507 1/20 0.32
TRPC6 Q9Y210 1/20 0.32
PKM P14618 1/20 0.32
SCD5 Q86SK9 3/20 0.31
SCD O00767 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6468229 0.95 BACE1 (0.37) BACE1BACE2SMN1; SMN2USP30TRPV1
SCHEMBL6465415 0.92 BACE1 (0.48) BACE1BACE2USP30TRPV1CPT2
SCHEMBL2727473 0.92 BACE1 (0.48) BACE1BACE2USP30TRPV1CPT2
SCHEMBL2727474 0.92 BACE1 (0.48) BACE1BACE2USP30TRPV1CPT2
SCHEMBL2725028 0.89 BACE1 (0.37) BACE1BACE2SMN1; SMN2USP30TRPV1
SCHEMBL2726988 0.87 SMN1; SMN2 (0.38) SMN1; SMN2TRPV1CPT2CPT1ACPT1B
SCHEMBL2726507 0.84 BACE1 (0.41) BACE1BACE2SMN1; SMN2TRPV1CPT1A
SCHEMBL2726509 0.84 BACE1 (0.41) BACE1BACE2SMN1; SMN2TRPV1CPT1A
SCHEMBL2726505 0.84 BACE1 (0.41) BACE1BACE2SMN1; SMN2TRPV1CPT1A
SCHEMBL2726356 0.84 TRPV1 (0.35) SMN1; SMN2TRPV1CPT2CPT1ACPT1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012054510-A1 OXADIAZOLE COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF COMENTIS, INC. (US) 2012-04-26 WO disclosed